| Company Name: |
SPIRO PHARMA |
| Tel: |
|
| Email: |
eric_feng1954@126.com |
Quinoline, 2-[[4-[1-Methyl-4-(4-pyridinyl)-1H-pyrazol-3-yl]phenoxy]Methyl]- ,succinate salt manufacturers
- MP-10 succinate
-
- $1980.00
-
2026-05-11
- CAS:1037309-45-7
- Purity:
- Supply Ability: 10g
|
| | Quinoline, 2-[[4-[1-Methyl-4-(4-pyridinyl)-1H-pyrazol-3-yl]phenoxy]Methyl]- ,succinate salt Basic information |
| | Quinoline, 2-[[4-[1-Methyl-4-(4-pyridinyl)-1H-pyrazol-3-yl]phenoxy]Methyl]- ,succinate salt Chemical Properties |
| | Quinoline, 2-[[4-[1-Methyl-4-(4-pyridinyl)-1H-pyrazol-3-yl]phenoxy]Methyl]- ,succinate salt Usage And Synthesis |
| Uses | Mardepodect succinate (PF-2545920 succinate) is a potent and specific phosphodiesterase 10A (PDE10A) inhibitor with potential activity in the treatment of schizophrenia. Mardepodect succinate has been further optimized to improve brain penetration and compound-like properties for use in schizophrenia research[1]. | | References | [1] Discovery of a novel class of phosphodiesterase 10A inhibitors and identification of clinical candidate 2-[4-(1-methyl-4-pyridin-4-yl-1H-pyrazol-3-yl)-phenoxymethyl]-quinoline (PF-2545920) for the treatment of schizophrenia |
| | Quinoline, 2-[[4-[1-Methyl-4-(4-pyridinyl)-1H-pyrazol-3-yl]phenoxy]Methyl]- ,succinate salt Preparation Products And Raw materials |
|